____________________________________________________________
Programme
____________________________________________________________
| Time | Session/Presenter/Topic |
19:00 - 21:00 | Welcome Reception - Composers Suite |
| Time | Session/Presenter/Topic |
08:00 - 09:00 09:00 - 09:10 09:10 - 11:00 | Registration Open Welcome Screening Programmes Session 1 The Italian Experience - Emanuele Bosi, Milan (09:10 - 09:30) The US Experience - Marian Rewers, Denver, Colorado (09:30 - 09:50) ELSA - Lauren Quinn, Birmingham (09:50 - 10:10) T1DRA - Kathleen Gillespie, Bristol (10:10 - 10:30) Panel discussion on implementing screening in the UK - All speakers, Primary Care Diabetes Society (10:30 - 11:00) |
11:00 - 11:30 | COFFEE BREAK |
11:30 - 13:00 | Screening Process Session 2Optimising Ab assays for T1D screening – Alex Richter, Birmingham (11:30 - 11:50) How can genetic analysis support the identification of children and adults with pre-symptomatic T1D? –Richard Oram, Exeter (11:50 - 12:10) Parallel ‘meet the expert’ sessions in breakout rooms a) Screening programmes (everyone from session 1) or b) The screening process (everyone from session 2) (12:20 - 13:00) |
13:00 - 14:00 | LUNCH |
14:00 - 17:00 | Research studies into Monitoring of pre-T1D Current UK Research Monitoring studies in Children - Loredana Marcovecchio, Cambridge (14:00 - 14:20) Current UK Research Monitoring studies in Adults - Anna Long, Bristol (14:20 - 14:40) Managing pre-T1D in UK clinical practice Monitoring children in UK clinical practice and the UK Ab Registry - Rachel Besser, Oxford (14:40 - 15:00) Accurate disease classification and monitoring of pre-T1D in adults - Nick Thomas, Exeter (15:00 - 15:20) Panel Discussion with Marc Atkin and Fulya Mehta, led by Fiona Campbell, Parth Narendran (15:20 - 16:00) Parallel ‘meet the expert’ sessions in breakout rooms a) Running a pre-T1D service in paediatrics (RD/RB) or b) Running a pre-T1D service in adults (NT/PN) (16:00 - 16:40) |
16:40 | CLOSE |
19:00 - 22:00 | Conference Dinner - Fry Suite |
| Time | Session/Presenter/Topic |
08:00 - 09:00 09:00 - 10:50 | Registration Open The psychological impact of early detection T1D, a summary of evidence so far - Olga Boiko, Birmingham (09:00 - 09:20) Prediction and prevention of rheumatoid arthritis: Perspectives of people at risk, patients, and healthcare professionals - Marie Falahee, University of Birmingham (09:20 - 09:40) Living with Chronic Uncertainty, examples from Cystic Fibrosis (CFSPID) - Felicity Boardman, University of Warwick (09:40 - 10:00) A patient experience of screening - 10 mins for family and adult (ELSA, T1DRA) (10:00 - 10:20) Panel discussion led by Felicity Boardman with all speakers (10:20 - 10:50) |
10:50 - 11:20 | COFFEE BREAK |
11:20 - 13:00 | Disease Modifying Therapy for T1D Lessons from MS - Gavin Giovannoni, London (11:20 - 11:40) The US Experience - Kimber Simmons, Denver (11:40 - 12:00) The UK Experience - Renuka Dias, Birmingham and Neil Wright, Sheffield (12:00 - 12:20) Navigating the practicalities of accessing and delivering a 14-day therapy - Phil Newland Jones, Southampton (12:20 - 12:40) Panel Discussion (12:40 - 13:00) |
13:00 - 14:00 | LUNCH |
14:00 - 15:30 | The Future Pipeline of DMTs in T1D - Emily Sims (14:00 - 14:30) The T1DRC, Platform trials and the future - Colin Dayan, Cardiff (14:30 - 15:00) |
15:30 | CLOSING REMARKS |
Disclaimer:
Sanofi have had no involvement in the agenda/speaker selection or the organisation of the meeting and are involved as an exhibitor only.